Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy

During rheumatoid arthritis (RA) treatment, long-term injection of antitumor necrosis factor α antibodies (anti-TNFα Abs) may induce on-target toxicities, including severe infections (tuberculosis [TB] or septic arthritis) and malignancy. Here, we used an immunoglobulin G1 (IgG1) hinge as an Ab lock...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yun-Chi, Chuang, Chih-Hung, Chuang, Kuo-Hsiang, Chen, I-Ju, Huang, Bo-Cheng, Lee, Wen-Han, Wang, Hsin-Ell, Li, Jia-Je, Cheng, Yi-An, Cheng, Kai-Wen, Wang, Jaw-Yuan, Hsieh, Yuan-Chin, Lin, Wen-Wei, Cheng, Tian-Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563948/
https://www.ncbi.nlm.nih.gov/pubmed/31194726
http://dx.doi.org/10.1371/journal.pbio.3000286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563948/
https://www.ncbi.nlm.nih.gov/pubmed/31194726
http://dx.doi.org/10.1371/journal.pbio.3000286

Ejemplares similares